MedTrace Logo

Postextubation Management in Patients at Risk for Extubation Failure

NCT04258020 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2022-01-13

Study results available
· View outcomes & findings →

Summary

At the time of weaning from mechanical ventilation, patients with heart and/or lung conditions will be given oxygen support with alternating bilevel positive airway pressure (BiPAP; oxygen via face mask) and heated high flow nasal cannula oxygen (HFNC; oxygen via nasal cannula) to see if this method reduces the likelihood of re-intubation.

Conditions

  • Ventilatory Failure

Interventions

DEVICE

BiPAP

Bilevel Positive Airway Pressure (BiPAP) oxygen administration

DEVICE

HFNC

Heated High Flow Nasal Cannula oxygen administration

Sponsors & Collaborators

  • OhioHealth

    lead OTHER

Principal Investigators

  • Kiran Devulapally, MD · OhioHealth

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-11
Primary Completion
2020-02-25
Completion
2020-04-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04258020 on ClinicalTrials.gov